Stratos Wealth Partners, Ltd. Incyte Corp Transaction History

Stratos Wealth Partners, Ltd.

  • $6.9 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 08, 2019
SELL
$58.5 - $69.94 $6,025 - $7,203
-103 Closed
0 $0
Q3 2018

Nov 02, 2018
BUY
$61.75 - $74.23 $6,360 - $7,645
103 New
103 $7,000
Q2 2018

Aug 13, 2018
SELL
$60.85 - $83.98 $6,267 - $8,649
-103 Closed
0 $0
Q4 2017

Feb 09, 2018
BUY
$93.56 - $116.6 $9,636 - $12,009
103
103 $10,000

Others Institutions Holding INCY

# of Institutions
657
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Stratos Wealth Partners, Ltd. Portfolio

Follow Stratos Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email